India, Jan. 12 -- Jubilant Biosys Limited,a wholly owned subsidiary of Jubilant Pharmova Limited, and a global CRDMO operating fromfivesites across India and Europe, has announced the opening of a new discovery and preclinical facility at Noida, doubling its overall chemistry capacity for discovery research and scale-up projects.

The multimillion-dollar facility combines discovery and early-phase scale-up capabilities with R&D labs and two pilot plants, meeting growing demand in particular forfee-for-service(FFS) contracts.

"We have grown rapidly over the past year, well above the wider market, by expanding our FFS offerings, which enable innovators to advance discovery projects with lower risk. With improving funding conditions, we ant...